File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial

TitleEfficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial
Authors
Lau, YLNelson, ESPoon, KHChan, KSChiu, SSSSung, RLeung, CWNg, DMa, YMChan, DLee, TLTang, JKwan, YWIp, PHo, MHKFung, LWTang, HSuryakiran, PVHan, HHBock, H
KeywordsEfficacy
Gastroenteritis
Hong Kong
Intussusception
Rotavirus
Safety
Issue Date2013
PublisherElsevier.
Citation
Vaccine, 2013, v. 31 n. 18, p. 2253-9 How to Cite?
DOI: http://dx.doi.org/10.1016/j.vaccine.2013.03.001
AbstractBACKGROUND: A phase III, double-blind, randomized, controlled trial was conducted in Hong Kong to evaluate the efficacy, safety and immunogenicity of a human rotavirus vaccine, RIX4414 (Rotarix) against severe rotavirus gastroenteritis in children up to three years of age.
Persistent Identifierhttp://hdl.handle.net/10722/203275
ISI Accession Number ID
WOS:000318329500006

 

DC FieldValueLanguage
dc.contributor.authorLau, YLen_US
dc.contributor.authorNelson, ESen_US
dc.contributor.authorPoon, KHen_US
dc.contributor.authorChan, KSen_US
dc.contributor.authorChiu, SSSen_US
dc.contributor.authorSung, Ren_US
dc.contributor.authorLeung, CWen_US
dc.contributor.authorNg, Den_US
dc.contributor.authorMa, YMen_US
dc.contributor.authorChan, Den_US
dc.contributor.authorLee, TLen_US
dc.contributor.authorTang, Jen_US
dc.contributor.authorKwan, YWen_US
dc.contributor.authorIp, Pen_US
dc.contributor.authorHo, MHKen_US
dc.contributor.authorFung, LWen_US
dc.contributor.authorTang, Hen_US
dc.contributor.authorSuryakiran, PVen_US
dc.contributor.authorHan, HHen_US
dc.contributor.authorBock, Hen_US
dc.date.accessioned2014-09-19T13:51:21Z-
dc.date.available2014-09-19T13:51:21Z-
dc.date.issued2013en_US
dc.identifier.citationVaccine, 2013, v. 31 n. 18, p. 2253-9en_US
dc.identifier.urihttp://hdl.handle.net/10722/203275-
dc.description.abstractBACKGROUND: A phase III, double-blind, randomized, controlled trial was conducted in Hong Kong to evaluate the efficacy, safety and immunogenicity of a human rotavirus vaccine, RIX4414 (Rotarix) against severe rotavirus gastroenteritis in children up to three years of age.en_US
dc.languageengen_US
dc.publisherElsevier.en_US
dc.relation.ispartofVaccineen_US
dc.subjectEfficacy-
dc.subjectGastroenteritis-
dc.subjectHong Kong-
dc.subjectIntussusception-
dc.subjectRotavirus-
dc.subjectSafety-
dc.titleEfficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trialen_US
dc.typeArticleen_US
dc.identifier.emailLau, YL: lauylung@hku.hken_US
dc.identifier.emailChiu, SSS: ssschiu@hku.hken_US
dc.identifier.emailLee, TL: leetsz@hkucc.hku.hken_US
dc.identifier.emailIp, P: patricip@hku.hken_US
dc.identifier.emailHo, MHK: marcoho@hku.hken_US
dc.identifier.authorityLau, YL=rp00361en_US
dc.identifier.authorityChiu, SSS=rp00421en_US
dc.identifier.authorityIp, P=rp01337en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1016/j.vaccine.2013.03.001en_US
dc.identifier.pmid23499605-
dc.identifier.scopuseid_2-s2.0-84875829509-
dc.identifier.hkuros236840en_US
dc.identifier.volume31en_US
dc.identifier.issue18en_US
dc.identifier.spage2253en_US
dc.identifier.epage9en_US
dc.identifier.isiWOS:000318329500006-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats